because
cholesterol-lowering medications can affect triglyceride
levels, the prevalence of hypertriglyceridemia
was calculated once based on serum triglyceride
concentrations and again based on serum
triglyceride concentration and/or the use of cholesterol-
lowering medications; (iv) patients taking
cholesterol-lowering medications were considered
to have met the low HDL-C criterion only if their
HDL-C was